Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US58506Q1094
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG0065B7K59
MEDP
Medpace Holdings Inc
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Diagnostics & Research · THEMEFOLIO: $HLTH
NAME
Medpace Holdings Inc
ISIN
US58506Q1094
TICKER
MEDP
MIC
XNAS
REUTERS
MEDP.OQ
BLOOMBERG
MEDP US
Wed, 08.04.2026       Medpace
US58506Q1094

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON M...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.04.2026       Medpace
US58506Q1094

Law Offices of Howard G. Smith announces an investigation on behalf of Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDPACE HOLDINGS, INC. (MEDP), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTE...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.04.2026       Medpace
US58506Q1094

The Law Offices of Frank R. Cruz announces an investigation of Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON MEDPACE HOLDINGS, INC. (MEDP), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CL...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.04.2026       Medpace
US58506Q1094

NEW YORK, April 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 a...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Medpace
US58506Q1094

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026. Medpace is a clinical contract research organization (CRO) focused on providing scientifically driven outsourced clinical developm...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Medpace
US58506Q1094

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026. Medpace describes itself as a “clinical contract research organization (CRO) focused on providing scientifically-driven outsourced clinical...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Medpace
US58506Q1094

The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders who purchased shares of MEDP during the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Medpace
US58506Q1094

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Inv...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 24.03.2026       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026. The Company will host a conference call the following morning, Thursday, April 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference cal...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 23.02.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP) concerning potential violations of the federal securities laws.On February 10, 2026, Medpace shares fell approximately 10% by mid-day and clos...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 18.02.2026       Medpace
US58506Q1094

(NASDAQ: MEDP)NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Medpace Holdings, Inc. (NASDAQ: MEDP) concerning potential securities law claims on behalf of shareholders. The investigation centers on whether the company and its senior officers made statements about the health of its clinical-trial booking pipeline...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.02.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP) concerning potential violations of the federal securities laws.On February 10, 2026, Medpace shares fell approximately 10% by mid-day and clos...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 09.02.2026       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Results Revenue for the three months ended December 31, 2025 increased 32.0% to $708.5 million, compared to $536.6 million for the comparable prior-year period. On a con...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 05.01.2026       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026. The Company will host a conference call the following morning, Tuesday, February 10, 2026, at 9:00 a.m. ET to discuss these results. To participate in...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.10.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Results Revenue for the three months ended September 30, 2025 increased 23.7% to $659.9 million, compared to $533.3 million for the comparable prior-year period. On a constant currency...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 23.09.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October 22, 2025. The Company will host a conference call the following morning, Thursday, October 23, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 21.07.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Results Revenue for the three months ended June 30, 2025 increased 14.2% to $603.3 million, compared to $528.1 million for the comparable prior-year period. On a constant currency basis,...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 23.06.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2025 financial results after the market close on Monday, July 21, 2025. The Company will host a conference call the following morning, Tuesday, July 22, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference call, in...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 21.04.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Results Revenue for the three months ended March 31, 2025 increased 9.3% to $558.6 million, compared to $511.0 million for the comparable prior-year period. On a constant currency basis, rev...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 18.03.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2025 financial results after the market close on Monday, April 21, 2025. The Company will host a conference call the following morning, Tuesday, April 22, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference call, in...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 10.02.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Results Revenue for the three months ended December 31, 2024 increased 7.7% to $536.6 million, compared to $498.4 million for the comparable prior-year period. On a cons...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.01.2025       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2024 financial results after the market close on Monday, February 10, 2025. The Company will host a conference call the following morning, Tuesday, February 11, 2025, at 9:00 a.m. ET to discuss these results. To participate in...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 22.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 22, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reporte...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 21.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 21, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reporte...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 20.11.2024       Medpace
US58506Q1094

RADNOR, Pa., Nov. 20, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace")....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 19.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 19, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reporte...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 18, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reporte...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 16.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 16, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").On October 21, 2024, during after-market hours, Medpace reported...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 15.11.2024       Medpace
US58506Q1094

RADNOR, Pa., Nov. 15, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace")....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 14.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 14, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").On October 21, 2024, during after-market hours, Medpace reported...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 13.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 13, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").On October 21, 2024, during after-market hours, Medpace reported...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 10.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 10, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").On October 21, 2024, during after-market hours, Medpace reported...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 10.11.2024       Medpace
US58506Q1094

NEW YORK, Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 09.11.2024       Medpace
US58506Q1094

RADNOR, Pa., Nov. 9, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace")....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.11.2024       Medpace
US58506Q1094

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 07.11.2024       Medpace
US58506Q1094

NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigati...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 04.11.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - November 4, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 02.11.2024       Medpace
US58506Q1094

NEW YORK, Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 31.10.2024       Medpace
US58506Q1094

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 31.10.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - October 31, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reporte...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.10.2024       Medpace
US58506Q1094

NEW YORK, Oct. 30, 2024 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP). Investors who purchased Medpace securities are encouraged to obtain additional information and assist the investigati...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.10.2024       Medpace
US58506Q1094

RADNOR, Pa., Oct. 30, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace")....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.10.2024       Medpace
US58506Q1094

Radnor, Pennsylvania--(Newsfile Corp. - October 29, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace").On October 21, 2024, during after-market hours, Medpace reported...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 25.10.2024       Medpace
US58506Q1094

NEW YORK, Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 25.10.2024       Medpace
US58506Q1094

LOS ANGELES, Oct. 25, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of the securities laws....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.10.2024       Medpace
US58506Q1094

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed t...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.10.2024       Medpace
US58506Q1094

RADNOR, Pa., Oct. 23, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace")....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.10.2024       Medpace
US58506Q1094

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) (“Medpace”). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its reve...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 21.10.2024       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results Revenue for the three months ended September 30, 2024 increased 8.3% to $533.3 million, compared to $492.5 million for the comparable prior-year period. On a constant currency ba...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink